— Know what they know.
Not Investment Advice

IME.AX ASX

ImExHS Limited
1W: +16.1% 1M: -7.1% 3M: -7.1% YTD: -27.8% 1Y: +44.4% 3Y: -48.8% 5Y: -77.4%
A$0.33 ($0.23)
+0.00 (+0.00%)
 
ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 48 · A$17.7M mcap · 52M float · 0.014% daily turnover

Income Trends

Revenue
$29M +9.0% ▲
5Y CAGR: +21.6%
Gross Profit
$8M -24.6% ▼
5Y CAGR: +25.2%
Operating Income
-$698K -90.0% ▼
Net Income
-$3M -9.8% ▼
EPS (Diluted)
$-0.06 +3.6% ▲
EBITDA
$2M +3234.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$13M$17M$20M$27M$29M
YoY Growth+22.5%+28.0%+14.9%+35.1%+9.0%
Cost of Revenue$8M$14M$16M$16M$21M
Gross Profit$5M$4M$3M$11M$8M
Gross Margin39.1%20.6%17.8%41.5%28.7%
R&D Expenses$1M$2M$2M$3M$0
SG&A Expenses$6M$6M$6M$8M$8M
Operating Expenses$7M$6M$9M$11M$9M
Operating Income-$3M-$2M-$3M-$367K-$698K
Operating Margin-23.5%-14.2%-13.7%-1.4%-2.4%
Interest Expense$311K$443K$332K$469K$375K
Income Before Tax-$5M-$3M-$4M-$3M-$3M
Tax Expense$143K$92K$173K$58K-$157K
Net Income-$5M-$3M-$4M-$3M-$3M
Net Margin-35.1%-17.8%-21.3%-9.9%-9.9%
EPS (Diluted)$-0.15$-0.09$-0.10$-0.06$-0.06
EBITDA-$3M-$744K-$1M$46K$2M
Shares Outstanding31M36M42M45M51M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms